Search Results - "van Veen, Ilonka"

A 37-Year-Old Woman With Recurrent Hemoptysis by Schoonbeek, Rosanne C., Wagenaar, Michiel, Baidoshvili, Alexi, van Veen, Ilonka H.P.A.A.

“…A 37-year-old woman presented with a 2-month history of recurrent hemoptysis and coughing. Her symptoms started 2 months after the delivery of her third child…”
Get full text

An optimized D-dimer cut-off value to predict pulmonary thromboembolism in COVID-19 patients by Engels, Sophie Y H, van Veen, Ilonka H P A A, Oudkerk, Matthijs, van der Palen, Job, Heuvelmans, Marjolein A

“…Pulmonary thromboembolism (PTE) is a common complication in coronavirus disease 2019 (COVID-19) patients. Elevated D-dimer levels are observed even in the…”
Get full text

Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma – First Initiators and Switchers by Hashimoto, Simone, Kroes, Johannes A., Eger, Katrien A., Mau Asam, Pearl F., Hofstee, Hendrik B., Bendien, Sarah A., Braunstahl, Gert Jan, Broeders, Marielle E.A.C., Imming, Leonie M., Langeveld, Bas, Maitland-van der Zee, Anke H., Oud, Karen T.M., Patberg, Kornelis Wiebe, Smeenk, Frank W.J.M., Romme, Elisabeth A.P.M., van Bezouw, Maarten J., van de Ven, Marjo J., van Veen, Anneke, van Velzen, Edwin, van Veen, Ilonka H.P.A.A., Weersink, Els J.M., Ten Brinke, Anneke, Sont, Jacob K., Bel, Elisabeth H.

“…Reslizumab, a biologic targeting IL-5, has been shown to reduce asthma exacerbations and maintenance oral corticosteroid use in randomized controlled trials…”
Get full text

Consistency of sputum eosinophilia in difficult-to-treat asthma: A 5-year follow-up study by van Veen, Ilonka H., MD, ten Brinke, Anneke, MD, PhD, Gauw, Stefanie A, Sterk, Peter J., MD, PhD, Rabe, Klaus F., MD, PhD, Bel, Elisabeth H., MD, PhD

“…Characteristics of patients and methods are described elsewhere in detail.3,6,7 In 1998 and 1999 (visit 1), patient characteristics (sex, age, atopic status,…”
Get full text

Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis by Bendien, Sarah A., Kroes, Johannes A., van Hal, Lotte H.G., Braunstahl, Gert-Jan, Broeders, Marielle E.A.C., Oud, Karen T.M., Patberg, Kornelis Wiebe, Smeenk, Frank W.J.M., van Veen, Ilonka H.P.A.A., Weersink, Els J.M., Fieten, Karin B., Hashimoto, Simone, van Veen, Anneke, Sont, Jaap K., van Huisstede, Astrid, van de Ven, Marjo J.T., Langeveld, Bas, Maitland-van der Zee, Anke-Hilse, ten Brinke, Anneke

“…Bronchiectasis is a common comorbidity in patients with asthma and is associated with increased disease severity. In patients with severe eosinophilic asthma,…”
Get full text

Exploring the feasibility, acceptability, usability and safety of a digitally supported self-management intervention for uncontrolled asthma: A pre-post pilot study in secondary care by Zijp, Anne, Versluis, Anke, Joosse, Laura, Kind, Taco, Rouveroy van Nieuwaal, Tess MJ, Wassink-Bergman, Chantal, van Veen, Ilonka HPAA, Weersink, Els JM, Chavannes, Niels H, Aardoom, Jiska J

“…Asthma control is often suboptimal, which is associated with incorrect medication use and poor asthma management by patients. Astmakompas, a digital…”
Get full text

Effectiveness of FeNO‐guided treatment in adult asthma patients: A systematic review and meta‐analysis by Korevaar, Daniël A., Damen, Johanna A., Heus, Pauline, Moen, Maaike J., Spijker, René, Veen, Ilonka H., Weersink, Els J., Kemenade, Geert‐Jan, Hal, Peter Th. W., Hooft, Lotty

“…Objective Asthma control is generally monitored by assessing symptoms and lung function. However, optimal treatment is also dependent on the type and extent of…”
Get full text

Long-Term Weight Changes After Starting Anti–IL-5/5Ra Biologics in Severe Asthma: The Role of Oral Corticosteroids by ten Have, Lianne, Visser, Edith, Meulmeester, Fleur L., Bendien, Sarah A., Braunstahl, Gert-Jan, Broeders, Marielle E.A.C., Fieten, Karin B., Hashimoto, Simone, van Huisstede, Astrid, Langeveld, Bas, Oud, Karen T.M., Patberg, Kornelis W., Smeenk, Frank W.J.M., van Veen, Anneke, van Veen, Ilonka H., van de Ven, Marjo J.T., Weersink, Els J.M., de Jong, Kim, Sont, Jacob K., Kroes, Johannes A., ten Brinke, Anneke

“…Many patients with severe asthma are overweight or obese, often attributed to unintentional weight gain as a side effect of oral corticosteroids (OCSs)…”
Get full text

Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial by Hashimoto, Simone, Brinke, Anneke Ten, Roldaan, Albert C, van Veen, Ilonka H, Möller, Gertrude M, Sont, Jacob K, Weersink, Els J M, van der Zee, Jaring S, Braunstahl, Gert-Jan, Zwinderman, Aeilko H, Sterk, Peter J, Bel, Elisabeth H

“…In patients with prednisone-dependent asthma the dose of oral corticosteroids should be adjusted to the lowest possible level to reduce long-term adverse…”
Get more information

Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma by van Veen, Ilonka H., ten Brinke, A., van der Linden, A.C., Rabe, K.F., Bel, E.H.

“…Persistent airflow limitation is common among patients with severe asthma, but its pathogenesis has not been fully clarified. Severe alpha-1-antitrypsin (AAT)…”
Get full text

Frequent exacerbators - a distinct phenotype of severe asthma by Kupczyk, M., ten Brinke, A., Sterk, P. J., Bel, E. H., Papi, A., Chanez, P., Nizankowska-Mogilnicka, E., Gjomarkaj, M., Gaga, M., Brusselle, G., Dahlén, B., Dahlén, S.-E.

“…Summary Background Exacerbations represent a major source of morbidity and mortality in asthma and are a prominent feature of poorly controlled,…”
Get full text

Mannose binding lectin (MBL) levels predict lung function decline in severe asthma by van Veen, IlonkaH, Hiemstra, PieterS, ten Brinke, Anneke, Roos, Anja, Verhoosel, RenateM, Sont, JaapK, Sterk, PeterJ, Rabe, KlausF, Bel, ElisabethH

“…* Dept of Pulmonology, Leiden University Medical Center, The Netherlands # Dept of Pulmonology, Medical Center Leeuwarden, Leeuwarden, The Netherlands ¶ Dept…”
Get full text